Study of Multi-mode Thermal Therapy Combined With Immunotherapy In Patients With HER2-negative Breast Cancer With Liver Metastases

NCT07466927 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

HER2-negative Breast Cancer

Interventions

DRUG: SHR-A1811
DRUG: SKB264
DRUG: Pembrolizumab
DRUG: SHR-1316

Sponsor

Fudan University